National guidelines for colorectal cancer screening in Saudi Arabia: Recommendations from the multi-society guideline development task force.
Researchers
Majid A Almadi, Resheed Alkhiari, Ammar Alotaibi, Fahad Alsohaibani, Ahmad Bazarbashi, Adel Alghamdi, Turki Alameel, Eman Al Sulais, Majid Alsahafi, Sarah Alghamdi, Faisal Batwa, Abdulaziz Almasood, Naser Alsanea, Mohammed Alghamdi, Fahad Ibnshamsah, Samar Alhomoud, Thamer Bin Traiki, Mohammed Alateeq, Mohammed Alzahrani, Abdulaziz M Alrabiah, Ghada F Al Yousif, Abdulaziz I Alalwan, Aymen Almuhaidb, Ohoud Alamoudi, Malak A AlShammari, Abdullah Almousa, Abdulrahman M Aljebreen
Abstract
These updated national guidelines were developed jointly by the Saudi Gastroenterology Association, Saudi Society of Colon and Rectal Surgery, Saudi Society of Gastrointestinal Oncology, and Saudi Society of Family and Community Medicine, and provide evidence-based recommendations for colorectal cancer (CRC) screening in Saudi Arabia, superseding the 2015 national guidelines. This update incorporates new epidemiological data from Saudi Arabia, including updated incidence estimates, polyp prevalence studies, colonoscopy quality audit data, and national screening uptake surveys, to provide a comprehensively evidence-anchored and locally contextualized framework. A national multidisciplinary group formulated 25 key Population, Intervention, Comparison, Outcome (PICO) questions across seven domains. Systematic literature searches were performed from inception to March 2026. Grading of Recommendations Assessment, Development and Evaluation (GRADE) evidence profiles were prepared for critical outcomes, and recommendations were developed through an iterative consensus process requiring ≥80% agreement for strong recommendations. The Task Force strongly recommends implementing an organized national CRC screening program for all asymptomatic average-risk adults aged 45 to 75 years. Biennial fecal immunochemical testing (FIT) is recommended as the primary population-based screening modality. Colonoscopy every 10 years is a recommended alternative. All positive FIT results must be followed by timely, high-quality colonoscopy. Specific recommendations are provided for high-risk groups. High-certainty evidence from multiple randomized trials and large-scale implementation studies demonstrates that organized CRC screening substantially reduces CRC-specific mortality and incidence. A phased, FIT-based national implementation strategy is recommended, tailored to Saudi epidemiology, population preferences, and healthcare infrastructure, with iterative quality improvement as new evidence emerges.Source: PubMed (PMID: 43050178)View Original on PubMed